27th Jan 2014 11:45
LONDON (Alliance News) - Futura Medical PLC said Monday it is continuing discussions with potential commercial partners ahead of the launch of its new CSD500 condom, as Ansell Ltd began the roll out of its PET500 product for premature ejaculation in the US.
Ansell has exclusive worldwide rights to the product. The product is sold under the name EPIC as part of Ansell's Lifestyles brand. The product uses Futura Medical's DermaSys delivery system.
Shares in Futura were trading down 1.2% at 68.70 pence.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright © 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Futura Medical